The Center for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) on Friday adopted a resolution that recommends individuals with compromised immune systems should receive a third dose of either the Pfizer or Moderna vaccine against the novel coronavirus.

“An additional dose of Pfizer-BioNTech COVID-19 vaccine (≥12 years) or Modern COVID-19 vaccine (≥18 years) is recommended following a primary series in immunocompromised people,” the ACIP said.

The ACIP approved the recommendation in a unanimous 11 – 0 vote after the US Food and Drug Administration on Thursday authorized the emergency use of the third dose of Pfizer or Moderna for immune-compromised individuals.